Buprenorphine + Naloxone Injection Generics - Manufacturers & Suppliers
Buprenex(US)
| Product/Composition:- | Buprenorphine + Naloxone Injection |
|---|---|
| Strength:- | 0.3 mg/mL, 0.6 mg/mL, 1 mg/mL |
| Form:- | Injection |
| Reference Brands:- | Buprenex(US) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Buprenorphine + Naloxone injection activates mu-opioid receptors, relieving severe pain, while Naloxone blocks opioid effects if injected illicitly, reducing misuse potential. Benefits include rapid, effective pain relief, opioid dependency management, and decreased overdose risk when used responsibly. Suitable for hospital or clinical pain management.
Buprenorphine + Naloxone injection is approved in the US and EU for opioid dependence treatment, primarily used in clinical settings. In the US, brands like Sublocade are regulated by the FDA, supported by comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality. In the EU, approval by EMA involves extensive dossiers, clinical data, and pharmacovigilance commitments. Due to high abuse potential, strict prescribing regulations and monitoring are enforced in both regions. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for buprenorphine + naloxone injection, ensuring adherence to European and US standards for safe, effective opioid dependency treatment.